You are here

CPS / RxTx 2 Renewal 2017-2018

Response Deadline: 
September 22, 2017

Subscription Term

Begins: 

October 1, 2017

Ends: 

March 31, 2018

Pricing is now available for another 6 month extension (October 1, 2017 - March 31, 2018) of the Canadian Pharmacists Association (CPhA) online Compendium of Pharmaceuticals and Specialties (CPS formerly e-CPS) and RxTx 2 (formerly e-Therapeutics+ which includes e-CPS & Therapeutic Choices). Pricing for both products has stayed the same as the previous 6 month extension.

Background: After multiple conversations, CPhA has again agreed to extend e-HLbc’s current license for 6 months at the same pricing model (as the previous 6-month extension) with no cost increase. In the short term this will save our institutions hundreds, if not thousands, of dollars while we continue our negotiations on an upcoming proposed pricing model which may include significant price increases.

Please note, our current license including this extension, does not include mobile access. But mobile access is a part of continued negotiations for a revised pricing model for 2018-2019.



Updates: 

In 2015 e-CPS and e-Therapeutics+ were moved to a new interface and were both renamed RxTx. For the purpose of e-HLbc's license renewal, we will now refer to the products as CPS (fomerly e-CPS) and RxTx 2 (formerly e-Therapeutics+).


Overview

Description: 

No longer offered by eHLbc.​

As described by the vendor:

CPS (formerly e-CPS) -- The Compendium of Pharmaceuticals and Specialties (CPS) is the Canadian standard for drug monographs developed by manufacturers and approved by Health Canada. CPS contains more than 2,000 product monographs for drugs, vaccines and natural health products, including 208 new monographs. This definitive resource also includes 164 CPhA monographs written by the Canadian Pharmacists Association's editorial staff, based on the best available evidence and reviewed by expert physicians and pharmacists. Clinical tools, product images and directories of drug and healthcare information are included.

RxTx 2 (formerly e-Therapeutics+) -- RxTx is Canada's authoritative source for prescribing and managing drug therapy at the point of care, providing health care professionals with online and mobile access to evidence-based, reliable Canadian drug and therapeutic information. RxTx integrates the content from our drug and therapeutic products into one convenient resource along with other valuable external references. RxTx 2 includes the Compendium of Pharmaceuticals and Specialties (CPS) and Compendium of Therapeutic Choices (CTC).

Response

Response Instructions

To RENEW, no response is required from current subscribers as listed above. To CANCEL or to CHANGE OPTIONS, libraries should contact BC ELN by the response deadline.

Terms & Conditions

Questions?